MPIN, Batch9, MPIN26 Morning Pitch 6/22/22 MPIN, Batch9, MPIN26 Morning Pitch 6/22/22 Zumutor Biologics Developer of monoclonal antibody therapeutics to treat cancer and infectious diseases. The company has developed a fully human proprietary mAb technology platform INABLR. Read More
MPIN, Batch9, MPIN26 Morning Pitch 6/22/22 MPIN, Batch9, MPIN26 Morning Pitch 6/22/22 Zumutor Biologics Developer of monoclonal antibody therapeutics to treat cancer and infectious diseases. The company has developed a fully human proprietary mAb technology platform INABLR. Read More
